MGLCX
Price
$17.66
Change
+$0.18 (+1.03%)
Updated
Jun 12 closing price
Net Assets
2.19B
RRSRX
Price
$33.01
Change
+$0.35 (+1.07%)
Updated
Jun 12 closing price
Net Assets
413.02M
Interact to see
Advertisement

MGLCX vs RRSRX

Header iconMGLCX vs RRSRX Comparison
Open Charts MGLCX vs RRSRXBanner chart's image
MGLCX vs RRSRX Comparison Chart in %
View a ticker or compare two or three
VS
MGLCX vs. RRSRX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLCX is a StrongBuy and RRSRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLCX has more cash in the bank: 2.19B vs. RRSRX (413M). RRSRX pays higher dividends than MGLCX: RRSRX (2.99) vs MGLCX (1.93). MGLCX was incepted earlier than RRSRX: MGLCX (11 years) vs RRSRX (10 years). MGLCX (1.94) is less costly to investors than RRSRX (1.02). RRSRX is a more actively managed with annual turnover of: 67.00 vs. MGLCX (35.00). RRSRX has a lower initial minimum investment than MGLCX: RRSRX (0) vs MGLCX (1000). RRSRX annual gain was more profitable for investors over the last year : 12.44 vs. MGLCX (8.53). RRSRX return over 5 years is better than : -0.52 vs. MGLCX (-11.28).
MGLCXRRSRXMGLCX / RRSRX
Total Expense Ratio1.930.92210%
Annual Report Gross Expense Ratio1.941.02190%
Fund Existence11 years10 years-
Gain YTD9.14710.13490%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.19B413M531%
Annual Yield % from dividends1.932.9965%
Returns for 1 year8.5312.4469%
Returns for 3 years16.6630.5954%
Returns for 5 years-11.28-0.522,168%
Returns for 10 years20.8223.6988%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPN67.712.52
+3.87%
Global Payments
RCUS23.800.50
+2.15%
Arcus Biosciences
FET52.960.57
+1.09%
Forum Energy Technologies
PEPG1.47-0.04
-2.65%
PepGen
FBLG0.93-0.03
-3.42%
FibroBiologics Inc.